Works by Zhang, Xuanye

Results: 28

Continuation of anti-PD-1 therapy plus physician-choice treatment beyond first progression is not associated with clinical benefit in patients with advanced non-small cell lung cancer.

Published in:

Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1151385

By:

Yixing Wang;
Sha Fu;
Xuanye Zhang;
Wei Du;
Linfeng Luo;
Yongluo Jiang;
Yixin Zhou;
Yuanyuan Zhao;
Yunpeng Yang;
Hongyun Zhao;
Wenfeng Fang;
Yan Huang;
Li Zhang;
Shaodong Hong

Publication type:

Article

Simulation and Error Analysis of Methane Detection Globally Using Spaceborne IPDA Lidar.

Published in:

Remote Sensing, 2023, v. 15, n. 13, p. 3239, doi. 10.3390/rs15133239

By:

Zhang, Xuanye;
Zhang, Miaomiao;
Bu, Lingbing;
Fan, Zengchang;
Mubarak, Ahmad

Publication type:

Article

Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients.

Published in:

Cancer Science, 2018, v. 109, n. 1, p. 199, doi. 10.1111/cas.13439

By:

Zhang, Xuanye;
Rao, Huilan;
Xu, Xiaolu;
Li, Zhihua;
Liao, Bing;
Wu, Hongmei;
Li, Mei;
Tong, Xiuzhen;
Li, Juan;
Cai, Qingqing

Publication type:

Article

Anti‐epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first‐line treatment for recurrent or metastatic nasopharyngeal carcinoma.

Published in:

Cancer Medicine, 2020, v. 9, n. 5, p. 1721, doi. 10.1002/cam4.2838

By:

Chen, Chen;
Zhou, Yixin;
Zhang, Xuanye;
Fu, Sha;
Lin, Zuan;
Fang, Wenfeng;
Yang, Yunpeng;
Huang, Yan;
Zhao, Hongyun;
Hong, Shaodong;
Zhang, Li

Publication type:

Article

Pre-Treatment Tumor Growth Rate Predicts Clinical Outcomes of Patients With Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD-1/PD-L1 Therapy.

Published in:

Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.621329

By:

He, Li-na;
Zhang, Xuanye;
Li, Haifeng;
Chen, Tao;
Chen, Chen;
Zhou, Yixin;
Lin, Zuan;
Du, Wei;
Fang, Wenfeng;
Yang, Yunpeng;
Huang, Yan;
Zhao, Hongyun;
Hong, Shaodong;
Zhang, Li

Publication type:

Article

Detection of Human Papillomavirus DNA, E6/E7 Messenger RNA, and p16<sup>INK4a</sup> in Lung Cancer: A Systematic Review and Meta-analysis.

Published in:

Journal of Infectious Diseases, 2023, v. 228, n. 8, p. 1137, doi. 10.1093/infdis/jiad295

By:

Li, Xiaoxuan;
Ling, Yihong;
Hu, Lina;
Zhang, Lihong;
Lin, Suxia;
Zhang, Xuanye;
Zang, Shengbing

Publication type:

Article

PB1733: LONG‐TERM FOLLOW‐UP FOR PATIENTS WITH T CELL LYMPHOBLASTIC LYMPHOMA/ ACUTE LYMPHOBLASTIC LEUKEMIA WHO RECEIVED MODIFIED BFM PROTOCOLS.

Published in:

HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000973792.31674.b9

By:

Gao, Yan;
Ping, Liqin;
Wang, Xiaoxiao;
Bai, Bing;
Zhang, Xuanye;
Cai, Qingqing;
LI, Zhi‐Ming;
He, Huang;
Yang, Liang;
Zhang, Yizhuo;
Huang, Huiqiang

Publication type:

Article

Spectral Efficient Neural Network-Based M-ary Chirp Spread Spectrum Receivers for Underwater Acoustic Communication.

Published in:

Arabian Journal for Science & Engineering (Springer Science & Business Media B.V. ), 2024, v. 49, n. 12, p. 16593, doi. 10.1007/s13369-024-08918-6

By:

Liu, Songzuo;
Zuberi, Habib Hussain;
Arfeen, Zuhair;
Zhang, Xuanye;
Bilal, Muhammad;
Sun, Zongxin

Publication type:

Article

Systemic chemotherapy and sequential locoregional radiotherapy in initially metastatic nasopharyngeal carcinoma: Retrospective analysis with 821 cases.

Published in:

Head & Neck, 2020, v. 42, n. 8, p. 1970, doi. 10.1002/hed.26130

By:

Huang, Tianying;
Su, Ning;
Zhang, Xuanye;
Ma, Shuyun;
Zhong, Guangzheng;
Tian, Xiaopeng;
Chen, Qiuyan;
Tang, Linglong;
Lu, Lixia;
Fang, Yu;
Cai, Jun;
Cai, Qingqing

Publication type:

Article

Optimizing the tumor shrinkage threshold for evaluating immunotherapy efficacy for advanced non-small-cell lung cancer.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 3, p. 1103, doi. 10.1007/s00432-022-03978-3

By:

Du, Wei;
Chen, Chen;
Luo, Lin-feng;
He, Li-na;
Wang, Yixing;
Zhang, Xuanye;
Zhou, Yixin;
Lin, Zuan;
Hong, Shaodong

Publication type:

Article

Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma.

Published in:

Signal Transduction & Targeted Therapy, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41392-020-00331-3

By:

Cai, Jun;
Liu, Panpan;
Huang, Huiqiang;
Li, Yajun;
Ma, Shuyun;
Zhou, Hui;
Tian, Xiaopeng;
Zhang, Yuchen;
Gao, Yan;
Xia, Yi;
Zhang, Xuanye;
Yang, Hang;
Li, Lirong;
Cai, Qingqing

Publication type:

Article

Survival Trends in Patients Under Age 65 Years With Mantle Cell Lymphoma, 1995–2016: A SEER-Based Analysis.

Published in:

Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.588314

By:

Wu, Hongyu;
Wang, Jianwei;
Zhang, Xuanye;
Yang, Hang;
Wang, Yu;
Sun, Peng;
Cai, Qingqing;
Xia, Yi;
Liu, Panpan

Publication type:

Article

Correction to: Hepatotoxicity associated with PD-1 blockade antibodies in cancer patients co-infected with hepatitis B virus.

Published in:

2022

By:

Lin, Zuan;
Zhang, Xuanye;
Zhou, Yixin;
Chen, Chen;
He, Li-na;
Li, Haifeng;
Wang, Yuhong;
Chen, Tao;
Hong, Shaodong;
Zhang, Li

Publication type:

Correction Notice

Hepatotoxicity associated with PD-1 blockade antibodies in cancer patients co-infected with hepatitis B virus.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 5, p. 1247, doi. 10.1007/s00262-021-03082-4

By:

Lin, Zuan;
Zhang, Xuanye;
Zhou, Yixin;
Chen, Chen;
He, Li-na;
Li, Haifeng;
Wang, Yuhong;
Chen, Tao;
Hong, Shaodong;
Zhang, Li

Publication type:

Article

Efficacy and safety of PD-L1 inhibitors versus PD-1 inhibitors in first-line treatment with chemotherapy for extensive-stage small-cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 637, doi. 10.1007/s00262-021-03017-z

By:

Yu, Hui;
Chen, Ping;
Cai, Xiuyu;
Chen, Chen;
Zhang, Xuanye;
He, Lina;
Zhou, Yixin;
Hong, Shaodong;
Zhang, Bei

Publication type:

Article

Second‐line treatment options in advanced thymic carcinoma after failure of platinum‐based chemotherapy: A multicenter retrospective study.

Published in:

Cancer Medicine, 2023, v. 12, n. 3, p. 2303, doi. 10.1002/cam4.5053

By:

Wang, Yang;
Zhang, Xuanye;
Tian, Dan;
Han, Sen;
Zhang, Jie;
Nie, Jun;
Dai, Ling;
Hu, Weiheng;
Chen, Xiaoling;
Ma, Xiangjuan;
Tian, Guangming;
Wu, Di;
Zhang, Ziran;
Long, Jieran;
Fang, Jian

Publication type:

Article

Mutations in Ras homolog family member A in patients with peripheral T-cell lymphoma and implications for personalized medicine.

Published in:

Cancer Biology & Medicine, 2024, v. 21, n. 9, p. 754, doi. 10.20892/j.issn.2095-3941.2024.0132

By:

Lina Hu;
Xuanye Zhang;
Shengbing Zang

Publication type:

Article

A CT‐based radiomics model to predict subsequent brain metastasis in patients with ALK‐rearranged non–small cell lung cancer undergoing crizotinib treatment.

Published in:

Thoracic Cancer, 2022, v. 13, n. 11, p. 1558, doi. 10.1111/1759-7714.14386

By:

Jiang, Yongluo;
Wang, Yixing;
Fu, Sha;
Chen, Tao;
Zhou, Yixin;
Zhang, Xuanye;
Chen, Chen;
He, Li‐na;
Du, Wei;
Li, Haifeng;
Lin, Zuan;
Zhao, Yuanyuan;
Yang, Yunpeng;
Zhao, Hongyun;
Fang, Wenfeng;
Huang, Yan;
Hong, Shaodong;
Zhang, Li

Publication type:

Article

Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma by Targeting the Epidermal Growth Factor Receptor Combined with Gemcitabine Plus Platinum.

Published in:

Cancer Management & Research, 2020, v. 12, p. 10353, doi. 10.2147/CMAR.S275947

By:

Chen, Chen;
Zhang, Xuanye;
Zhou, Yixin;
Fu, Sha;
Lin, Zuan;
Hong, Shaodong;
Zhang, Li

Publication type:

Article

Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitor.

Published in:

Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231200463

By:

He, Li-Na;
Chen, Tao;
Fu, Sha;
Jiang, Yongluo;
Zhang, Xuanye;
Chen, Chen;
Du, Wei;
Luo, Linfeng;
Li, Anlin;
Wang, Yixing;
Yu, Hui;
Zhou, Yixin;
Wang, Yuhong;
Yang, Yunpeng;
Huang, Yan;
Zhao, Hongyun;
Fang, Wenfeng;
Zhang, Li;
Hong, Shaodong

Publication type:

Article

Accuracy of next-generation sequencing for molecular profiling of small specimen of lung cancer: a prospective pilot study of side-by-side comparison.

Published in:

Diagnostic Pathology, 2022, v. 17, n. 1, p. 1, doi. 10.1186/s13000-022-01255-y

By:

Ben, Xiaosong;
Tian, Dan;
Zhuang, Weitao;
Chen, Rixin;
Wang, Sichao;
Zhou, Zihao;
Deng, Cheng;
Shi, Ruiqing;
Liu, Songlin;
Zhang, Dongkun;
Tang, Jiming;
Xie, Liang;
Zhou, Haiyu;
Zhang, Zhou;
Li, Min;
Zhang, Xuanye;
Qiao, Guibin

Publication type:

Article

Unsatisfied Reporting Quality of Clinical Trials Evaluating Immune Checkpoint Inhibitor Therapy in Cancer.

Published in:

Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.736943

By:

Chen, Chen;
Zhou, Yixin;
Zhang, Xuanye;
Wang, Yuhong;
He, Li-na;
Lin, Zuan;
Chen, Tao;
Jiang, Yongluo;
Hong, Shaodong;
Zhang, Li

Publication type:

Article

Targeting TET2 as a Therapeutic Approach for Angioimmunoblastic T Cell Lymphoma.

Published in:

Cancers, 2022, v. 14, n. 22, p. 5699, doi. 10.3390/cancers14225699

By:

Hu, Lina;
Zhang, Xuanye;
Li, Huifeng;
Lin, Suxia;
Zang, Shengbing

Publication type:

Article

[Cuproptosis-related immune gene signature predicts clinical benefits from anti-PD-1/PD-L1 therapy in non-small-cell lung cancer.

Published in:

Immunologic Research, 2023, v. 71, n. 2, p. 213, doi. 10.1007/s12026-022-09335-3

By:

Luo, Linfeng;
Li, Anlin;
Fu, Sha;
Du, Wei;
He, Li-Na;
Zhang, Xuanye;
Wang, Yixing;
Zhou, Yixin;
Yunpeng, Yang;
Li, Zhang;
Hong, Shaodong

Publication type:

Article

Neoadjuvant-Adjuvant vs Neoadjuvant-Only PD-1 and PD-L1 Inhibitors for Patients With Resectable NSCLC: An Indirect Meta-Analysis.

Published in:

JAMA Network Open, 2024, v. 7, n. 3, p. e241285, doi. 10.1001/jamanetworkopen.2024.1285

By:

Zhou, Yixin;
Li, Anlin;
Yu, Hui;
Wang, Yuhong;
Zhang, Xuanye;
Qiu, Huijuan;
Du, Wei;
Luo, Linfeng;
Fu, Sha;
Zhang, Li;
Hong, Shaodong

Publication type:

Article

Clinical characterization and outcome of primary bone lymphoma: a retrospective study of 61 Chinese patients.

Published in:

Scientific Reports, 2016, p. 28834, doi. 10.1038/srep28834

By:

Zhang, XuanYe;
Zhu, Jun;
Song, YuQin;
Ping, LingYan;
Zheng, Wen

Publication type:

Article

LRRC3B and its promoter hypomethylation status predicts response to anti-PD-1 based immunotherapy.

Published in:

Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.959868

By:

Linfeng Luo;
Sha Fu;
Wei Du;
Li-na He;
Xuanye Zhang;
Yixing Wang;
Yixin Zhou;
Shaodong Hong

Publication type:

Article

PD-1 inhibition plus platinum-based chemotherapy (PBC) or PBC alone in the first-line treatment of locally advanced or metastatic pulmonary lymphoepithelioma- like carcinoma.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1015444

By:

Xuanye Zhang;
Yixin Zhou;
Hualin Chen;
Chen Chen;
Zuan Lin;
Li-na He;
Wei Du;
Tao Chen;
Shaodong Hong;
Sha Fu

Publication type:

Article